| Nome |
# |
|
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease, file dfe4d229-e50f-bb0a-e053-d805fe0a78d9
|
55
|
|
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes, file de2b4ef2-ae7b-4a73-8728-87db91cca00a
|
48
|
|
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici, file dfe4d22c-b121-bb0a-e053-d805fe0a78d9
|
39
|
|
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells, file dfe4d22d-e820-bb0a-e053-d805fe0a78d9
|
33
|
|
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction, file dfe4d22c-2708-bb0a-e053-d805fe0a78d9
|
32
|
|
Increased Platelet Reactivity and Proinflammatory Profile Are Associated with Intima-Media Thickness and Arterial Stiffness in Prediabetes, file 6ca9812f-d34d-4786-af79-753fbafc4927
|
24
|
|
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy, file dfe4d22e-d122-bb0a-e053-d805fe0a78d9
|
24
|
|
Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease, file b7448123-80fb-4016-8974-ca8de5773402
|
23
|
|
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress, file dfe4d228-9533-bb0a-e053-d805fe0a78d9
|
19
|
|
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production, file dfe4d22d-02ca-bb0a-e053-d805fe0a78d9
|
17
|
|
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation, file 119c4373-00c1-4080-ab1f-184de171338b
|
16
|
|
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy, file dfe4d229-e570-bb0a-e053-d805fe0a78d9
|
16
|
|
Clinical evaluation of bempedoic acid for the treatment of hyperlipidaemia, file c463d2aa-74bd-42f9-9d31-aa29c8956def
|
15
|
|
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome, file dfe4d229-8752-bb0a-e053-d805fe0a78d9
|
15
|
|
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways, file dfe4d22e-96b7-bb0a-e053-d805fe0a78d9
|
14
|
|
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity, file 7ff3a030-be08-4574-900d-6096489e332f
|
13
|
|
Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome, file aebb6a98-1ef0-4156-965f-85819373fb5d
|
13
|
|
Left ventricular geometry and periodontitis in patients with the metabolic syndrome, file dfe4d229-d81c-bb0a-e053-d805fe0a78d9
|
12
|
|
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation, file dfe4d22e-abc0-bb0a-e053-d805fe0a78d9
|
12
|
|
Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies, file 8cee3855-49bb-4893-b064-f95c2ce98df3
|
11
|
|
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation, file dfe4d229-e181-bb0a-e053-d805fe0a78d9
|
11
|
|
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview, file dfe4d22c-cc57-bb0a-e053-d805fe0a78d9
|
11
|
|
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN), file dfe4d22c-f6c1-bb0a-e053-d805fe0a78d9
|
11
|
|
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience, file dfe4d22e-8d9e-bb0a-e053-d805fe0a78d9
|
11
|
|
Clinical and molecular biomarkers for diagnosis and staging of nafld, file dfe4d22e-9045-bb0a-e053-d805fe0a78d9
|
11
|
|
High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications, file dfe4d22e-96b5-bb0a-e053-d805fe0a78d9
|
11
|
|
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity, file dfe4d22e-aa49-bb0a-e053-d805fe0a78d9
|
11
|
|
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting, file dfe4d22e-b01e-bb0a-e053-d805fe0a78d9
|
11
|
|
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study, file dfe4d22c-f6c2-bb0a-e053-d805fe0a78d9
|
10
|
|
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis, file dfe4d22d-ec0d-bb0a-e053-d805fe0a78d9
|
9
|
|
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group, file 144f1b9b-4107-45b2-a70b-bd7c42164ab7
|
8
|
|
Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice, file 1879644b-8fe6-404e-b444-e24cdadc131c
|
8
|
|
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk, file bfc0d831-fcfc-4360-850f-d441eab24ec5
|
8
|
|
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study, file dfe4d22e-66d8-bb0a-e053-d805fe0a78d9
|
8
|
|
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress, file dfe4d22e-7a00-bb0a-e053-d805fe0a78d9
|
8
|
|
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department, file 9a516267-f92a-4b63-b473-db7f400715e7
|
7
|
|
Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN), file dfe4d22e-7d79-bb0a-e053-d805fe0a78d9
|
7
|
|
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome, file dfe4d22e-8d6f-bb0a-e053-d805fe0a78d9
|
7
|
|
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group, file c64008a6-3372-43b4-822a-40ad0aa97cbb
|
6
|
|
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria, file dfe4d227-25c2-bb0a-e053-d805fe0a78d9
|
6
|
|
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units, file 3681117f-a02a-46e0-a653-0e7a30993890
|
5
|
|
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia, file 6aa7e7db-8375-436e-8edf-63a46611dd59
|
5
|
|
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study, file dfe4d228-eaea-bb0a-e053-d805fe0a78d9
|
5
|
|
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience, file dfe4d22d-ec0f-bb0a-e053-d805fe0a78d9
|
5
|
|
Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications, file e45a6543-de9a-4dc1-b6d9-0f4bbb787c15
|
5
|
|
PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk, file f20e33f7-b459-4c1e-b4b9-4b1fb23eabf5
|
5
|
|
Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study, file fa9451f9-c581-424c-84e2-39f6650b3b09
|
5
|
|
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia, file 3befed05-4911-46a6-9297-719b327e7267
|
4
|
|
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience, file dfe4d22a-5914-bb0a-e053-d805fe0a78d9
|
4
|
|
May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?, file dfe4d22c-4001-bb0a-e053-d805fe0a78d9
|
4
|
|
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia, file dfe4d22c-e0ca-bb0a-e053-d805fe0a78d9
|
4
|
|
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients, file 0347e48d-6daf-4415-889e-83e28368d099
|
3
|
|
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease, file 4f800ac9-a0a9-4ee7-bd9d-bda39a2550ba
|
3
|
|
HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients, file dfe4d227-aba9-bb0a-e053-d805fe0a78d9
|
3
|
|
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes, file dfe4d22c-ff99-bb0a-e053-d805fe0a78d9
|
3
|
|
Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile, file dfe4d22e-9511-bb0a-e053-d805fe0a78d9
|
3
|
|
Endothelial Dysfunction and Heart Failure with Preserved Ejection Fraction—An Updated Review of the Literature, file 7c42b54f-fb88-4685-8ad0-9dbf64265639
|
2
|
|
Impatto del profilo lipidico sulla malattia aterosclerotica in due differenti coorti di pazienti ad alto rischio cardiovascolare, file 96addd10-b055-46c9-8374-05f2c9d28ff7
|
2
|
|
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes, file dfe4d227-25c1-bb0a-e053-d805fe0a78d9
|
2
|
|
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes, file dfe4d22c-b58a-bb0a-e053-d805fe0a78d9
|
2
|
|
Comparison of Total Cortisol, Free Cortisol, and Surrogate Markers of Free Cortisol in Diagnosis of Adrenal Insufficiency in Patients with Stable Cirrhosis., file dfe4d22e-7b34-bb0a-e053-d805fe0a78d9
|
2
|
|
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects, file dfe4d22e-adb2-bb0a-e053-d805fe0a78d9
|
2
|
|
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study, file f34ec97f-59d9-4d6c-a1e1-578742baabcd
|
2
|
|
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study, file 1cbb1f05-5f71-4375-954f-3fb977901828
|
1
|
|
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network, file 29c9ecb6-cc51-47ad-91a7-c3f3d06713f2
|
1
|
|
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia, file c8afaa66-1534-49dd-a69b-f886b400cb90
|
1
|
|
Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: a possible role in glucocorticoid deficiency, file dfe4d226-fe1b-bb0a-e053-d805fe0a78d9
|
1
|
|
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects, file dfe4d228-fd1c-bb0a-e053-d805fe0a78d9
|
1
|
|
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study, file dfe4d229-b6a0-bb0a-e053-d805fe0a78d9
|
1
|
|
Author's reply to: Arterial stiffness improvement after adding on PCSK9 inhibitors in patients with familial hypercholesterolemia, a letter from Papaioannou and colleagues, file dfe4d22c-434a-bb0a-e053-d805fe0a78d9
|
1
|
|
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects, file dfe4d22c-6ddb-bb0a-e053-d805fe0a78d9
|
1
|
|
Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease, file dfe4d22e-7ae7-bb0a-e053-d805fe0a78d9
|
1
|
|
Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies, file dfe4d22e-7dc7-bb0a-e053-d805fe0a78d9
|
1
|
|
Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units, file dfe4d22e-adb0-bb0a-e053-d805fe0a78d9
|
1
|
|
The impact of obesity and dyslipidemia on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study, file dfe4d22e-e1d3-bb0a-e053-d805fe0a78d9
|
1
|
| Totale |
723 |